Binding characteristics of high-affinity dopamine D2/D3 receptor agonists,11C-PPHT and11C-ZYY-339 in rodents and imaging in non-human primates by PET
- 1 November 2004
- Vol. 54 (2) , 83-91
- https://doi.org/10.1002/syn.20068
Abstract
We have evaluated the in vitro autoradiographic binding characteristics and in vivo brain distribution of two high‐affinity dopamine D2/D3 receptor agonists, (±)‐2‐(N‐phenethyl‐N‐1′‐11C‐propyl)amino‐5‐hydroxytetralin (11C‐PPHT) and (±)‐2‐(N‐cyclohexylethyl‐N‐1′‐11C‐propyl)amino‐5‐hydroxytetralin (11C‐ZYY‐339) in rodents and in monkeys using positron emission tomography (PET). In vitro autoradiograms in rat brain slices with 11C‐PPHT and 11C‐ZYY‐339 revealed binding to dopaminergic regions in the striata, which was substantially (>90%) displaced by 10 μM sulpiride. Striatal binding was also removed in the presence of 5‐guanylylimidophosphate (Gpp(NH)p), indicative of binding of these radiotracers to the high‐affinity (HA) state. The results of in vivo studies in rats exhibited binding of the two radiotracers to the striata (striata/cerebellum approached 2 in 30 min). The regional selectivity to the striata was reduced by preadministration of haloperidol. PET studies in male rhesus monkeys using an ECAT EXACT HR+ scanner indicated localization of 11C‐PPHT and 11C‐ZYY‐339 in the striata and thalamus. Striata to cerebellum and thalamus to cerebellum ratios were low (1.5 and 1.3, respectively, at 30 min postinjection) for both 11C‐PPHT and 11C‐ZYY‐339, apparently due to the slower nonspecific clearance from cerebellum. These findings with 11C‐PPHT and 11C‐ZYY‐339 indicate the possibility of in vivo imaging of high‐affinity state of dopamine D2/D3 receptors in both the striata and the thalamus. Synapse 54:83–91, 2004.Keywords
This publication has 20 references indexed in Scilit:
- In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐racloprideSynapse, 2004
- Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5′-18F-fluoropentyl)aminotetralin (18F-5-OH-FPPAT) in rodents and nonhuman primatesNuclear Medicine and Biology, 2004
- Alcohol‐withdrawn animals have a prolonged increase in dopamine D2Highreceptors, reversed by general anesthesia: Relation to relapse?Synapse, 2004
- Anesthetics inhibit high‐affinity states of dopamine D2 and other G‐linked receptorsSynapse, 2003
- Brain imaging of18F‐fallypride in normal volunteers: Blood analysis, distribution, test‐retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D‐2/D‐3 receptorsSynapse, 2002
- Specific Binding of [11C]Raclopride and N-[3H]Propyl-Norapomorphine to Dopamine Receptors in Living Mouse Striatum: Occupancy by Endogenous Dopamine and Guanosine Triphosphate–Free G ProteinJournal of Cerebral Blood Flow & Metabolism, 2002
- (−)-N-[11C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D2 receptorsNuclear Medicine and Biology, 2000
- Agonist high and low affinity state ratios predict drug intrinsic activity and a revised Ternary complex mechanism at serotonin 5-HT2A and 5-HT2C receptorsSynapse, 1999
- Dopamine D2 receptors mapped in rat brain with [3H](+)PHNOSynapse, 1994
- Complete Conversion of Brain D2 Dopamine Receptors from the High‐ to the Low‐Affinity State for Dopamine Agonists, Using Sodium Ions and Guanine NucleotideJournal of Neurochemistry, 1985